Last updated on March 2018

Study for Pediatric ADHD

Brief description of study

Study for Pediatric ADHD

Detailed Study Description

Study for Pediatric ADHD

Learning that your 4 to 12 year old child has attention-deficit/hyperactivity disorder (ADHD) is challenging. It may leave you wondering what options are available for your child and whether they will be safe for your child at such a young age. 

New clinical research studies will evaluate whether an investigational drug is safe and effective in children ages 4 to 12.

What is the purpose of the clinical research studies?

The studies will evaluate whether the study investigational drug is safe and effective in children with ADHD who are 4 to 12 years old. Different doses of the investigational drug will also be evaluated. 

Who can participate? 

With your permission as a parent or legal guardian, your child may qualify for a study if he or she is 4 to 12 years old and has ADHD symptoms such as increased levels of hyperactivity, inattentiveness, or impulsiveness. 

There are other requirements for participation in a study that the study doctor and staff will explain to you in detail during the informed consent process. 

To learn more or to see if your child may be eligible to participate in a study, visit

Clinical Study Identifier: TX133449

Contact Investigators or Research Sites near you

Start Over

Research Center

Research Center
Bloomfield Hills, MI USA
  Connect »